MINIMAL BILE ACID MALABSORPTION AND NORMAL BILE ACID BREATH TESTS IN CYSTIC FIBROSIS AND ACQUIRED PANCREATIC INSUFFICIENCY
|
|
- Madeleine Cole
- 5 years ago
- Views:
Transcription
1 GASTROENTEROLOGY 72:661--&i5, 1977 Copyright 1977 by The American Gastroenterological Association Vol. 72, No. 4, Part 1 Printed in U.s.A. MINIMAL BILE ACID MALABSORPTION AND NORMAL BILE ACID BREATH TESTS IN CYSTIC FIBROSIS AND ACQUIRED PANCREATIC INSUFFICIENCY RICHARD J. ROLLER, M.D., AND FRED KERN, JR., M.D. Division ofgastroenterowgy, University o f C olorado School of Medicine, Denver, Colorado This study was undertaken because of reports of a marked incrase in fecal bile acid excretion by childre with cystic fibrosis. We attempted to confirm this finding by performing [V 4 Clcholylglycine breath tests and by measuring fecal bile acid and fat excretion in patients with cystic fibrosis and acquired pancreatic insufficiency. Studies were done when patients were taking pancreatic enzymes (Cotazym) and also without medication. 14C0 2 excretion in breath was normal in patients with acquired pancreatic insufficiency and even lower in cystic fibrosis, both with and without Cotazym therapy. Fecal bile acid excretion was slightly elevated in both groups without Cotazym and became normal with Cotazym in patients with acquired pancreatic insufficiency. Steatorrhea was present in both patient groups and improved during Cotazym therapy. Bile acid malabsorption in cystic fibrosis and acquired pancreatic insufficiency is minimal and probably not clinically important. The enterohepatic circulation of bile acids in normal subjects is an efficient process. During each day the bile acid pool circulates 6 to 10 times, yet only 2 to 5% of the total pool is lost in the feces with each cycle. 2 These losses are greatly magnified when the enterohepatic circulation is broken, as it is in patients with ileal disease or resection. 3 The bile acid pool shrinks, often resulting in steatorrhea and lithogenic bile, and the excess bile acids entering the colon cause diarrhea. 3, 4 Weber et aj.5 found that the enterohepatic circulation is also broken in children with cystic fibrosis, who lose almost 7 times more fecal bile acids than do control subjects. The magnitude of the loss is comparable to that which occurs after ileal resection. Watkins et al. 6 reported a decrease in bile acid pool size and an increase in fractional turnover rate of cholic acid in a group of 6 children with untreated cystic fibrosis. Evidence of intact mucosal bile acid absorption and normal hepatic regulation of synthesis led them to implicate an intraluminal factor causing bile acid malabsorption. In a few adults with acquired pancreatic insufficiency, bile acid Received July 12, Accepted September 28, An abstract of this work has been published. 1 Address requests for reprints to: Dr. Richard J. Roller, University of Colorado Medical Center, Division of Gastroenterology, 4200 East 9th Avenue, Denver, Colorado This study was supported by Grant AM12626 from the United States Public Health Service, National Institutes of Health and by the Clinical Research Center RR-51, of the University of Colorado Medical Center. Dr. Roller's work was supported by Veterans Administration Gastroenterology Training Grant 110. The authors are grateful to Dr. Ernest Cotton, Department of Pediatrics, Dr. William R. Waddell, Department of Surgery, for referring patients, and to Patricia Coan for expert technical assistance. absorption was normal. 7,8 To elucidate these puzzling findings, we measured fecal bile acid and fecal fat excretion in patients with cystic fibrosis and acquired pancreatic insufficiency, before and during pancreatic enzyme replacement. We also performed the [1-14Clcholylglycine breath test,8-10 a sensitive test of bile acid malabsorption, and compared the results to those in control subjects and in patients with ileal resection. Patients and Methods Patients. Investigations were performed in the Clinical Research Unit and in the Gastrointestinal Laboratory under a research protocol approved by the Radiation Safety Committee and the Human Research Committee, University of Colorado Medical Center. Informed consent was obtained from adult patients or the parents of minors. Only males with cystic fibrosis were studied, because they are sterile and would be endangered less by irradiation. Normal control subjects were 7 men and 4 women, ages 19 to 68 (mean 51), with no evidence of pancreatic, hepatobiliary, or gastrointestinal disease. Diarrhea controls were 6 men and 4 women, ages 24 to 72 (mean 45), with diarrhea of various causes (ulcerative colitis, postgastrectomy, functional) but without roentgenographic or clinical evidence of ileal disease or bacterial overgrowth. There were 5 men and 5 women, ages 23 to 79 (mean 54), who had ileal resections of 28 to 300 cm, measured from the ileocecal valve, for Crohn's disease (5), mesenteric vascular insufficiency (3), actinomycosis (1), and carcinoid tumor (1). Nine patients, 7 men and 2 women, ages 32 to 73 (mean 53) had acquired pancreatic insufficiency as a result of chronic alcoholic pancreatitis (3), Whipple's operation for carcinoma (5), or traumatic pancreatitis (1). The 8 cystic fibrosis patients were males, ages 11 to 24 (mean 18), with pancreatic and pulmonary involvement. One additional patient with cystic fibrosis had had the distal 50% of his small bowel resected for meconium ileus at birth and was considered separately. All had stopped taking antibiotics at least 1 week before the study. 661
2 662 ROLLER AND KERN Vol. 72, N o.4, Part 1 Methods. The [V 4 Clcholylglycine breath test was performed in all subjects. Patients with cystic fibrosis or acquired pancreatic insufficiency had the test while they were receiving Cotazym (Organon, Inc., Toronto, Canada) and again at least 4 days after Cotazym had been discontinued. [1-14C1Cholylglycine, 5 to 10 JLC, specific activity 52 JLC per mmole (Amersham/Searle, Arlington Heights, Ill.) dissolved in 1 ml of ethanol, was given orally, followed immediately by 150 ml of water, to fasting, sedentary patients. s A standard hospital meal was given 2 hr later. Exhaled breath was collected hourly for 6 hr by passage over anhydrous CaS04, and 1 mmole of COz was trapped in a scintillation vial containing 1 ml of 1 M Hyamine hydroxide in methanol (Packard Instrument Co., Inc., LaGrange, Ill.), and 2 ml of methanol. Phenolphthalein was used to indicate neutralization. The exact quantity of COz collected was calculated from the concentration of Hyamine, which was determined by titration of the stock solution with hydrochloric acid. Radioactivity of 14COz in the vial was measured in a liquid scintillation counter (2425, Packard Instrument Company, Inc.). Results were expressed as total 14CO Z in expired breath after 6 hr, as a percentage of administered dose, with the assumption that the average CO 2 in expired breath is 9 mmoles per kg of body weight per hr." For fecal fat determinations, patients with cystic fibrosis or acquired pancreatic insufficiency were fed a measured 100-g fat diet and stools were collected for 72 hr. Fecal fat and fecal bile acid excretion were measured while the patients were taking Cotazym and again at least 4 days after it had been discontinued. The dose of Cotazym varied from 12 to 51 capsules per day. In every patient it was the same as or more than the patient's customary dose, depending on symptoms and gross appearance of stools. Fecal fat was determined by the method of Van de Kamer et al., 12 as modified by Anderson et al.,13 and expressed as grams of fat per 100 g of dietary fat per 24 hr (normal <5). Total fecal bile acids were measured by the hydroxy steriod dehydrogenase (Sigma Chemical Co., St. Louis, Mo.) assay, using a previously described modification. 14 The recovery of added deoxycholate, lithocholate, and conjugates of cholate averaged 88%, and measured values were appropriately corrected. The statistical significance of the differences between groups was evaluated by Student's t-test, and paired data were analyzed by the paired t-test. Results 14C0 2 excretion in breath after administration of [1-14Clcholylglycine did not differ significantly between normal and diarrhea control groups (table 1). They were therefore considered together as a combined control group. The range of normal cumulative 6-hr 14C0 2 breath excretion for our laboratory was defined as the combined control group mean ± 2 SD (0 to 4.97%). Patients with ileal resection, except 1 with only a 28-cm resection, had abnormal breath tests, implying bile acid malabsorption (control 2.7 ± 0.44%, patients ± 1.41 %; P < 0.001). 14C0 2 breath excretion in the acquired pancreatic insufficiency group, despite Cotazym therapy, was the same as in the control group, implying normal bile acid absorption (table 1, fig. 1). Two patients in this group did have slightly abnormal breath tests. Both had had operations for pancreatic carcinoma, and neither had clinical evidence of small intestinal bacterial overgrowth or ileal disease. No patient with cystic fibrosis alone had an abnormal breath test either with or without Cotazym. In fact, 14C0 2 breath excretion in this group was significantly lower than that of the controls (P < 0.005). The 1 patient with cystic fibrosis and ileal resection had abnormal breath tests, not affected by Cotazym therapy, indicating bile acid malabsorption. All patients with cystic fibrosis or acquired pancreatic insufficiency had steatorrhea (table 2). During pancreatic enzyme replacement therapy fecal fat decreased in both groups (P < 0.05), but many individuals had a poor response. Therapy was more effective in the ac- TABLE 1. Results of [l -'"'C]cholylglycine breath tests for each patient and control subject Acquired pancreatic insufficiency Cystic fibrosis Normal Diarrhea Ileal controls controls resection With Without With Without Cotazyrn Cotazyrn Cotazyrn Cotazyrn '"'C0 2 breath excretion/6 hr as % of administered dose b ' Mean ± SEM ±0.44 ±0.34 ±1.41 ±0.62 ±0.66 ±0.09 pc < NS NS <0.005 a Results for the patient with cystic fibrosis and ileal resection: with Cotazym, 8.63%; without Cotazym, 9.82.%. b Normal range, defined as mean of normal and diarrhea controls ± 2 so: (0 to 4.97%). c Significance of difference between each group mean and combined control group mean, 2.38 ± 0.25, analyzed by Student's t-test; NS, not significant ±0.21 <0.005
3 April BILE ACID ABSORPTION IN PANCREATIC INSUFFICIENCY 663 N'lO N l ~ ~ 5 0 N 9 ILEAL RE5(CTION N l FIG CO. breath excretion in 6 hr as percentage of administered dose for each group. breath at the rate of9 mmoles per kg of body weight per hr in the basal state. If this assumption were not valid for adolescents with cystic fibrosis, our conclusions could be erroneous. If one assumes that cystic fibrosis patients, because of age and disease, excrete CO 2 at double the normal rate, an unlikely but theoretically possible rate, the results of the breath test would be doubled. This is, the mean 14C0 2 excretion for the untreated patients would be 1.16% in 6 hr, which is still less than one-half of the control value. There are no data about endogenous CO2 production in such patients, but the basal oxygen consumption of adults with pulmonary emphysema is about 10% less than that of controls. 16 Watkins et al. 6 speculated that bile acids are malabsorbed because they are bound intraluminally to some product of digestion. If such binding prevented exposure quired pancreatic insufficiency group than in the cystic fibrosis group, as shown by lower fecal fat during Cotazym therapy (P < 0.05). This occurred despite the higher average dose of Cotazym in the cystic fibrosis group (38 capsules per day) than in the acquired pancreatic insufficiency group (20 capsules per day). The 1 patient with cystic fibrosis and ileal resection had steatorrhea which was only slightly improved by therapy. There was a minimal increase in fecal bile acid excretion in untreated patients with cystic fibrosis and acquired pancreatic insufficiency (table 3). Treatment with Cotazym caused a significant decrease in fecal bile acids in the acquired pancreatic insufficiency, but not in the cystic fibrosis group. Discussion These studies failed to confirm the marked increase in fecal bile acid excretion found by Weber et al. 5 [1-14C]Cholylglycine breath tests did not detect any bile acid malabsorption in our cystic fibrosis patients, and fecal bile acids were only minimally elevated. The mean fecal bile acid excretion of normal infants and children is 6.1 mg per kg per day, with a range of 1.9 to 11.6 mg per kg per day. 14 Normal adults excrete 200 to 650 mg per day, or for a 70-kg man, 3 to 9 mg per kg per day,2.15 and patients with ileal resection excrete a mean of 2553 mg per day, or 36.5 mg per kg per day. 7 Fecal bile acid excretion in our cystic fibrosis patients was only about twice normal, and not nearly as much as in patients with ileal resection. Almost all patients with ileal resection have increased breath 14C0 2 excretion after oral administration of [l- 14 C]cholylglycine If patients with cystic fibrosis have bile acid malabsorption of comparable magnitude, this breath test should detect it. 14C0 2 excretion was increased in 9 of 10 patients with ileal resection and in the 1 with cystic fibrosis and ileal resection, but in none with cystic fibrosis alone. 14C0 2 excretion was actually lower in the cystic fibrosis group than in controls. The calculation of the percentage of the administered [1-14C]cholylglycine excreted is based on the assumption that the average individual excretes CO 2 in expired TABLE 2. Fecal {at values {or patients with and without Cotazym Mean ± SEM pd Cystic fibrosis" Acquired insufficiency With Without With Without Cotazym Cotazym Cotazym Cotazym g/24 hr/loo g dietary {atb ND c ND ND ND < 0.05 < 0.05 a Results for the patient with cystic fibrosis and ileal resection: with Cotazym 24.2; without Cotazym b Normal less than 5. C Not done. d Significance of differences analyzed by paired t-test. TABLE 3. Fecal bile acid values {or patients with and with Cotazym Cystic fibrosis Acquired insufficiency With Without With Without Cotazym Cotazym Cotazym Cotazym mg/kg body wt/24 hr NDb ND ND ND Mean ± SEM ±2.02 ±1.96 ± 1.98 ±3.95 p c NS <0.05 a Results for the patient with cystic fibrosis and ileal resection: with Cotazym 27.3; without Cotazym b Not done. (. Significance of differences analyzed by paired t-test; NS, not significant.
4 664 ROLLER AND KERN Vol. 72, No.4, Part 1 of the bile acid-amide bond from colonic bacteria, deconjugation might be prevented, causing false negative breath tests. Yet binding of bile acids by cholestyramine does not prevent d ~ c o n j u 8 galthough a t i o n colonic. bacteria in cystic fibrosis patients have not been studied, it seems unlikely that their microflora would lack the deconjugating enzymes, which are present in so many different species offecal microorganismsy We are unable to explain why 14C02 excretion in the cystic fibrosis patients was even lower than in control subjects. In the two published studies, pancreatic replacement therapy in patients with cystic fibrosis decreased fecal bile acid loss,5 increased bile acid pool, and decreased bile acid fractional turnover rate. 6 Similar studies have not been reported in patients with acquired pancreatic insufficiency. In pancreatic exocrine insufficiency of any cause, such therapy decreases steatorrhea. 5,18-20 Although Cotazym significantly improved steatorrhea in both cystic fibrosis and acquired pancreatic insufficiency patients, the response was variable, and mean fecal fat excretion remained above normal in both groups. Despite a smaller dose of Cotazym, acquired pancreatic insufficiency patients had a better response than did those with cystic fibrosis, possibly explaining why fecal bile acid excretion returned to normal during therapy in the acquired pancreatic insufficiency patients but not in the cystic fibrosis patients. There is little published information on bile acid malabsorption in acquired pancreatic insufficiency. Fecal bile acid excretion was normal in 1 patient, 7 but in unpublished studies by Mietinnen et ai., 21 "slight bile acid malabsorption" was found. Bile acid breath tests have also been normal in several such patients. 8 The slight bile acid malabsorption in our acquired pancreatic insufficiency patients is of the same magnitude as in cystic fibrosis patients and may have a common cause. The cystic fibrosis patients we studied were older than those studied by Weber et aj.5 (mean age 4.9 years) and Watkins et al. 6 (range 3 months to 4 1 /2 years). These older patients represent a selected group-the survivors from the population of younger patients with cystic fibrosis - but severity of pulmonary disease, not pancreatic disease, is the major influence on survival. 22 Pancreatic insufficiency was as severe in our group as in those previously studied. In patients with cystic fibrosis and acquired pancreatic insufficiency, bile acid malabsorption is minimal and probably not clinically important. We were unable to confirm by either of two techniques the marked bile acid malabsorption found in other studies of cystic fibrosis. Note Added in Proof In an important paper which we previously overlooked, Goodchild et al. 23 published data that resolves, to a large extent, the discrepancy between our findings and those of Weber et al. 5 and Watkins et al. 6 Goodchild and her associates studied fecal bile acid excretion in 29 patients with cyctic fibrosis, varying in age from a few months to 20 years. Their data show that bile acid excretion was clearly greater in young patients «12 years, N = 21) than in the older group (N = 8): 24.2 mg per kg per 24 hr in the younger group versus 5.1 in the older group. In both groups, patients with liver disease, who presumably had a decreased bile acid pool size, had a smaller fecal bile acid excretion. For example, in the 4 older patients with liver disease the mean daily fecal bile acid excretion was 3.4 mg and in those without liver disease it was 7.2 mg per kg per 24 hr. The latter figure is identical to the fecal bile acid excretion in their 11 control subjects and slightly less than we found in our older cystic fibrosis patients, none of whom had liver disease. REFERENCES 1. Roller J, Kern F Jr: Minimal bile acid (BA) malabsorption and normal BA breath tests in cystic fibrosis (CF) and acquired pancreatic insufficiency (API) (abstr). Gastroenterology 70:930, Small DM, Dowling RH, Redinger RN: The enterohepatic circulation of bile acids. Arch Intern Med 130: , Hofmann AF: The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology 52: , Kelly TR, Klein RL, Woodford JW: Alterations in gallstone solubility following distal ileal resection. Arch Surg 105: , Weber AM, Roy CC, Merin CL, et al: Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 289: , Watkins JB, Tercyak AM, Szczepanik P, et al: Bile salt kinetics in cystic fibrosis: Influence of pancreatic enzyme replacement (abstr). Gastroenterology 68:1087, Woodbury JF, Kern F: Fecal excretion of bile acids: a new technique for studying bile acid kinetics in patients with ileal resection. J Clin Invest 50: , Sherr HP, Sasake Y, Newman A, et al: Detection of bacterial deconjugation of bile salts by a convenient breath-analysis technique. N Engl J Med 285: , Fromm H, Hofmann AF: Breath test for altered bile acid metabolism. Lancet 2: , Fromm H, Thomas PJ, Hofmann AF: Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B12 absorption in ileal resection patients. Gastroenterology 64: , Abt AF and Von Schuching SL: Fat utilization test in disorders offat metabolism. Bull Johns Hopkins Hosp 119: , Van de Kamer JH, ten Bokkel Juinink H, Weyers HA: Rapid method for the determination of fat in feces. J BioI Chern 177: , Anderson CM, Frazer AC, et al: Coeliac disease: gastrointestinal studies and the effect of dietary wheat flour. Lancet 1: , Weber AM, Chartrand L, Deyen G, et al: The quantitative determination of fecal bile acids in children by the enzymatic method. Clin Chim Acta 39: , Ali SS, Kuksis A, Beveridge JM: Excretion of bile acids by three men on a fat-free diet. Can J Biochem 44: , McGregor M, Becklake M: The relationship of oxygen cost of breathing to respiratory mechanical work and respiratory force. J Clin Invest 40: , Lewis R, Gorbach S: Modification of bile acids by intestinal bactera. Arch Intern Med 130: , Ross CA: Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis. Arch Dis Child 30: , KaIser MH, Leite CA, Warren WD: Fat assimilation after mas-
5 April 1977 BILE ACID ABSORPTION IN PANCREATIC INSUFFICIENCY 665 sive distal pancreatectomy. N Engl J Med 279: , Jordan P, Grossman M: Effect of dosage schedule on the efficacy of substitution therapy in pancreatic insufficiency. Gastroenterology 36: , Miettinen TA, Ahrens EH, Grundy 8M: Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res 6: , Guide to Diagnosis and Management of Cystic Fibrosis. Prepared by Professional Education Committee, Chairman CF Doershuk, National Cystic Fibrosis Research Foundation, 1971, Atlanta 23. Goodchild MC, Murphy GM, Howell AM, et al: Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child 50: , 1975
Table 1 Clinical findings of diabetics. hypoglycemic agent
Table 1 Clinical findings of diabetics 1)oral hypoglycemic agent Fig. 3 The ratio of primary bile acid to total bile acid Fig. 1 Fecal wet weight Fig. 4 Fecal fatty acid Fig. 2 Fecal bile acid excretion
More informationBile Salt Malabsorption in Pancreatic Insufficiency Secondary to Alcoholic Pancreatitis
GASTROENTEROLOGY 1986;91:1243-9 Bile Salt Malabsorption in Pancreatic Insufficiency Secondary to Alcoholic Pancreatitis S. K. DUTTA, K. ANAND, and T. R. GADACZ Department of Medicine and Surgery, Baltimore
More informationThe effect of coeliac disease upon bile salts
Gut, 1973, 14, 24-2 T. S. LOW-BEER,1 K. W. HEATON, E. W. POMARE, AND A. E. READ From the University Department of Medicine, Bristol Royal Infirmary SUMMARY The size and composition of the bile salt pool
More informationRelationship between bile acid malabsorption and
Gut, 1976, 17, 295-299 Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis A. M. WEBER1, C. C. ROY, L. CHARTRAND, G. LEPAGE,. L. DUFOUR, C. L. MORN, AND R. LASALLE
More informationTests of Bile-acid and Vitamin B 12 Metabolism in Ileal Crohn's Disease
Tests of Bile-acid and Vitamin B Metabolism in Ileal Crohn's Disease SIRUS FARIVAR, M.D., HANS FROMM, M.D., DETLEF SCHINDLER, M.D., BRITTAIN McJUNKIN, M.D., AND FRIEDRICH W. SCHMIDT Farivar, Sirus, Fromm,
More informationIrritable Bowel Syndrome: Last year FODMAPs, this year bile acids
Irritable Bowel Syndrome: Last year FODMAPs, this year bile acids Lana Bistritz, MD FRCPC Division of Gastroenterology Royal Alexandra Hospital Disclosures I have no financial conflicts of interest relevant
More informationStart Module 2: Physiology: Bile, Bilirubin. Liver and the Lab
Start Module 2: Physiology: Bile, Bilirubin Liver and the Lab Bile Physiology WYNTKFTB (Intro to Pathology) Applied Anatomy Components Function Synthesis Enterohepatic circulation Imbalance of components
More informationMalabsorption: etiology, pathogenesis and evaluation
Malabsorption: etiology, pathogenesis and evaluation Peter HR Green NORMAL ABSORPTION Coordination of gastric, small intestinal, pancreatic and biliary function Multiple mechanisms Fat protein carbohydrate
More informationDigestion and Absorption
Digestion and Absorption Digestion and Absorption Digestion is a process essential for the conversion of food into a small and simple form. Mechanical digestion by mastication and swallowing Chemical digestion
More informationBacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative
Patient: SAMPLE PATIENT DOB: Sex: MRN: 3.2 0.9-26.8 U/g 1.2 0.2-3.3 mg/g 2.2 1.3-8.6 micromol/g 1.1 1.3-23.7 mg/g 1.1 0.2-3.5 mg/g Rare 1.0 0.2-8.8 mg/g Rare 4.4 2.6-32.4 mg/g 64.6 >= 13.6 micromol/g Bacteriology
More informationShort Bowel Syndrome: Medical management
Short Bowel Syndrome: Medical management La Sindrome dell'intestino Corto in età pediatrica Brescia 18 marzo 2011 Jon A.Vanderhoof, M.D. Division of Pediatric GI Harvard Medical School Children s Hospital,
More informationEffect of dietary fiber on intestinal gas production and small bowel transit time in man13
ffect of dietary fiber on intestinal gas production and small bowel transit time in man13 John H. Bond,4 M.D. and Michael D. Levitt,5 M.D. ABSTRACT The influence of dietary fiber on intestinal gas production
More informationPATTERNS OF BILE ACIDS AND MICROFLORA IN THE HUMAN SMALL INTESTINE
G ASTROENTEROLOG Y Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.1 Printed in U.S.A. PATTERNS OF BILE ACIDS AND MICROFLORA IN THE HUMAN SMALL INTESTINE I. Bile acids ANDREW MALLORY, M.D., FRED
More informationSIBO
SIBO What is it? Small Intestinal Bowel Overgrowth A chronic bacterial infection of the small intestine Caused by bad bacteria such as E Coli and Clostridium migrating to the small intestine There is not
More informationBILE FORMATION, ENTEROHEPATIC CIRCULATION & BILE SALTS
1 BILE FORMATION, ENTEROHEPATIC CIRCULATION & BILE SALTS Color index Important Further explanation 2 Mind map...3 Functions of bile & stages of bile secretion... 4 Characteristics & composition of bile...5
More informationStagnant loop syndrome in patients with continent
Gut, 1977, 18, 795-799 tagnant loop syndrome in patients with continent ileostomy (intra-abdominal ileal reservoir) H. CHJNBY1, J. F. HALVOREN, T. HOFTAD, AND N. HOVDENAK From the University of Bergen,
More informationMETABOLISM OF STEROID AND AMINO ACID MOIETIES OF CONJUGATED BILE ACIDS IN MAN
GASTROENTEROLOGY 72:141-148, 1977 Copyright 1977 by The Williams & Wilkins Co. Vol. 72, No.1 Printed in U.S.A. METABOLISM OF STEROID AND AMINO ACID MOIETIES OF CONJUGATED BILE ACIDS IN MAN V. Equations
More informationEsophageal Disorders. Gastrointestinal Diseases. Peptic Ulcer Disease. Wireless capsule endoscopy. Diseases of the Small Intestine 7/24/2010
Esophageal Disorders Gastrointestinal Diseases Fernando Vega, MD HIHIM 409 Dysphagia Difficulty Swallowing and passing food from mouth via the esophagus Diagnostic aids: Endoscopy, Barium x ray, Cineradiology,
More informationLIVER PHYSIOLOGY AND DISEASE
GASTROENTEROLOGY 64: 298-303, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.2 Printed in U.S.A. LIVER PHYSIOLOGY AND DISEASE BILE ACID METABOLISM IN CIRRHOSIS III. Biliary lipid secretion
More informationEffect of Cholestyramine on Bile Acid Metabolism in Normal Man
Effect of Cholestyramine on Bile Acid Metabolism in Normal Man J. T. GAisurr and T. J. KENNEY From the Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, North
More informationChronic diarrhea. Dr.Nasser E.Daryani Professor of Tehran Medical University
1 Chronic diarrhea Dr.Nasser E.Daryani Professor of Tehran Medical University Timing Acute diarrhea: 4 weeks Definitions Derived from Greek
More informationBile acid metabolism. doc. Ing. Zenóbia Chavková, CSc.
Bile acid metabolism doc. Ing. Zenóbia Chavková, CSc. Bile acid metabolism Importance: Availability for fat & cholesterol absorption Regulates total body pool of cholesterol Factors that synthesis promote
More informationDUCKWORTH, Naftalin and Dalgarno
Fat Studies in Poultry 6. UTILIZATION OF FATS OF DIFFERENT MELTING POINTS* B. MARCH AND JACOB BIELY Poultry Nutrition Laboratory,^ The University of British Columbia, Vancouver, B. C, Canada DUCKWORTH,
More informationLower Gastrointestinal Tract KNH 406
Lower Gastrointestinal Tract KNH 406 Lower GI Tract A&P Small Intestine Anatomy Duodenum, jejunum, ileum Maximum surface area for digestion and absorption Specialized enterocytes from stem cells of crypts
More informationPlasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection
Plasma levels and intestinal absorption of 25hydroxyvitamin D in patients with small bowel resection JULIET E. COMPTON AND B. CREAMER From t. Thomas' Hospital, London Gut, 1977, 18, 171175 UMMARY Plasma
More informationINCREASED RATIO OF GLYCINE- TO TAURINE-CONJUGATED BILE SALTS IN PATIENTS WITH ILEAL DISORDERS
GASTROENTEROLOGY Copyright 1969 by The Williams & Wilkins Co. Vol. 56, No. 4 Printed in U.S.A. INCREASED RATIO OF GLYCINE- TO TAURINE-CONJUGATED BILE SALTS IN PATIENTS WITH ILEAL DISORDERS J. T. GARBUTT,
More informationEnterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man
Gut, 1979, 20, 1078-1082 Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man K. A. EINARSSON,' S. M. GRUNDY, AND W. G. M. HARDISON From the Department of Meaicine, School of
More informationDespicable Diarrhea. Darlene G. Kelly, MD, PhD Associate Professor of Medicine Medical Director HPN Program Mayo Clinic Rochester, Minnesota
Despicable Diarrhea Darlene G. Kelly, MD, PhD Associate Professor of Medicine Medical Director HPN Program Mayo Clinic Rochester, Minnesota Conflict of Interest Statement Commercial Interests None Off
More informationCHRONIC DIARRHEA DR. PHILIP K. BLUSTEIN M.D. F.R.C.P.(C) DEFINITION: *LOOSE, WATERY STOOLS *MORE THAN 3 TIMES A DAY *FOR MORE THAN 4 WEEKS
DR. PHILIP K. BLUSTEIN M.D. F.R.C.P.(C) 415 14 TH ST. NW. CALGARY AB T2N2A1 PHONE (403) 270-9555 FAX (403) 270-7479 CHRONIC DIARRHEA DEFINITION: *LOOSE, WATERY STOOLS *MORE THAN 3 TIMES A DAY *FOR MORE
More informationHydrophobic Surfactant Treatment Prevents Atherosclerosis in the Rabbit
Hydrophobic Surfactant Treatment Prevents Atherosclerosis in the Rabbit RAPID PUBLICATIONS J. B. RODGERS, E. C. KYRIAKIDES, B. KAPUSCINSKA, S. K. PENG, and W. J. BOCHENEK, Department of Medicine, Albany
More informationLIVER PHYSIOLOGY AND DISEASE
GASTROENTEROLOGY 68: 326-334, 1975 Copyright 1975 by The Williams & Wilkins Co. Vol. 68, No.2 Printed in U.S.A. LIVER PHYSIOLOGY AND DISEASE EFFECTS OF LOW DOSE CHENODEOXYCHOLIC ACID FEEDING ON BILIARY
More informationNutritional assessments and diagnosis of digestive disorders
Nutritional assessments and diagnosis of digestive disorders AASER ABDELAZIM Assistant professor of Medical Biochemistry Zagazig University, Egypt University of Bisha, KSA aaserabdelazim@yahoo.com 7 Mal
More informationFecal incontinence causes 196 epidemiology 8 treatment 196
Subject Index Achalasia course 93 differential diagnosis 93 esophageal dysphagia 92 95 etiology 92, 93 treatment 93 95 work-up 93 Aminosalicylates, pharmacokinetics and aging effects 36 Antibiotics diarrhea
More informationSmall Bowel Obstruction after operation in a severely malnourished man. By: Ms Bounmark Phoumesy
Small Bowel Obstruction after operation in a severely malnourished man By: Ms Bounmark Phoumesy Normal length of GI tract Normal length(achieved by age 9) Small bowel 600cm (Men: 630 cm; Women: 592 cm)
More information6.2.1 Exocrine pancreatic insufficiency
6.2.1 Exocrine pancreatic insufficiency Authors: Jean Louis Frossard, Alain Sauty 1. INTRODUCTION Exocrine pancreatic insufficiency is a biological and clinical condition that is characterized by a progressive
More informationEFFECT OF CARBENOXOLONE ON THE GASTRIC MUCOSAL BARRIER IN MAN AFTER ADMINISTRATION OF TAUROCHOLIC ACID
GASTROENTEROLOGY 64: 1101-1105, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64 No.6 Printed in U.S.A. EFFECT OF CARBENOXOLONE ON THE GASTRIC MUCOSAL BARRIER IN MAN AFTER ADMINISTRATION OF TAUROCHOLIC
More informationThe Importance of Glutamine and Antioxidant Vitamin Supplementation in HIV
The Importance of Glutamine and Antioxidant Vitamin Supplementation in HIV An Introduction to Glutamine Glutamine is the most abundant amino acid in the human body, and plays extremely important role in
More informationDiagnosis of chronic Pancreatitis. Christoph Beglinger, University Hospital Basel, Switzerland
Diagnosis of chronic Pancreatitis Christoph Beglinger, University Hospital Basel, Switzerland Pancreatitis Pancreas Pancreas - an organ that makes bicarbonate to neutralize gastric acid, enzymes to digest
More informationCystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation
Parkland College A with Honors Projects Honors Program 2013 Cystic Fibrosis Monica Rahman Parkland College Recommended Citation Rahman, Monica, "Cystic Fibrosis" (2013). A with Honors Projects. 98. http://spark.parkland.edu/ah/98
More informationChapter 3 The Role of Nutrition in CF Care
Chapter 3 The Role of Nutrition in CF Care S. King, N. Saxby & N. Sander Cystic fibrosis is the most common lethal autosomal recessive genetic condition affecting Caucasians 186,187. Over 3500 Australians
More informationGRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM
GASTROENTEROLOGY 64: 1071-1076, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.6 Printed in U.S.A. GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM JAMES A. NELSON,
More informationAbsorption studies in patients six to 10 years after
Gut, 1979, 2, 499-53 Absorption studies in patients six to 1 years after construction of ileostomy reservoirs L.. NILSSON, H. ANDERSSON, L. HULTtN, R. JAGENBURG, N. G. KOCK, H. E. MYRVOLD, AND B. PHILIPSON
More informationClinical Evaluation of CHRONIC DIARRHEA. By Dr. Mohamed El-Awady
Clinical Evaluation of CHRONIC DIARRHEA By Dr. Mohamed El-Awady Definition Stool weight of more than 300 gm / 24 h more than 4 weeks (Feldman et al 2002) CLINICAL CLASSIFICATION 1) Large-Volume Versus
More informationWhat location in the gastrointestinal (GI) tract has tight, or impermeable, junctions between the epithelial cells?
CASE 32 A 17-year-old boy presents to his primary care physician with complaints of diarrhea for the last 2 days. The patient states that he just returned to the United States after visiting relatives
More informationrabbit, 45 min for dog) and more slowly for dehydrocholic acid (25- decrease, questioning the mechanism by which bile acids increase bile
J. Physiol. (1972), 224, pp. 259-269 259 With 6 text-ftgure8 Printed in Great Britain SPECIES DIFFERENCES IN THE CHOLERETIC RESPONSE TO BILE SALTS BY CURTIS D. KLAASSEN From the Clinical Pharmacology and
More informationA total of 111 subjects admitted consecutively in a. of diseases associated with malabsorption. Informed
J Clin Pathol 1981;34:174-178 One-hour serum ylose as an absorption test in the tropics PG HILL, IN ROSS,* R JACOB, S JYOTHEESWARAN, AND VI MATHAN From the Wellcome Research Unit and The Gastroenterology
More informationTotal body water and total body potassium in patients with continent ileostomies
Gut, 1982, 23, 589-593 Total body water and total body potassium in patients with continent ileostomies L 0 NILSSON, H ANDERSSON, I BOSAEUS, and H E MYRVOLD From the Department ofsurgery II and Department
More informationCitation for published version (APA): Minich, D. M. (1999). Essential fatty acid absorption and metabolism Groningen: s.n.
University of Groningen Essential fatty acid absorption and metabolism Minich, Deanna Marie IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationPARENTERAL NUTRITION THERAPY
UnitedHealthcare Benefits of Texas, Inc. 1. UnitedHealthcare of Oklahoma, Inc. 2. UnitedHealthcare of Oregon, Inc. UnitedHealthcare of Washington, Inc. UnitedHealthcare West BENEFIT INTERPRETATION POLICY
More informationPharmacokinetic Model for the Metabolism and Enterohepatic Circulation of Bile Acids in Man
Description and Simulation of a Physiological Pharmacokinetic Model for the Metabolism and Enterohepatic Circulation of Bile Acids in Man CHOLIC ACID IN HEALTHY MAN A. F. HOFMANN, Division of Gastroenterology,
More informationMCT AND THE ROLES NUTRITION
MCT AND THE ROLES NUTRITION Nguyen Hoang Nhut Hoa Department of Nutrition Children's Hospital 2 OBJECTIVES Structure Absorption and metabolic Effects of MCT in the treatment of certain diseases Demand
More informationBacteriology. Mycology. Genova Diagnostics SAMPLE REPORT. Rare. Rare. Negative. Brown. Negative *NG. Negative
Completed: November 2010 Genova Diagnostics eceived: October 2010 Collected: October 2010 oute Number:7 4.2 0.9-26.8 U/g 0.9 0.2-3.3 mg/g 0.8 1.3-8.6 micromol/g 42.7 1.3-23.7 mg/g 1.7 0.2-3.5 mg/g are
More informationD. N. Kim, K. T. Lee, J. M. Reiner, and W. A. Thomas MATERIALS AND METHODS. Experimental animals. Experimental design
Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine D. N. Kim, K.
More informationDetection of Small Intestine Bacterial Overgrowth by Means of a 14C-D-Xylose Breath Test
GASTROENTEROLOGY 77:75-82, 1979 Detection of Small Intestine Bacterial Overgrowth by Means of a 14C-D-Xylose Breath Test CHARLES E. KING, PHILLIP P. TOSKES, JOHN C. SPIVEY, ERHARD LORENZ, and SUSAN WELKOS
More informationPancreatic enzyme addition to the list
Pancreatic enzyme addition to the list Explanation for addition Ontario Public Drug Program (OPDP) data- financial year 2015/2016: the number of recipients was 3, and cumulative total number of claims
More informationFocus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis
Focus on (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Autosomal recessive, multisystem
More informationPancreatic replacement therapy in the treatment of pancreatic steatorrhoea
Gut, 1963, 4, 217 Pancreatic replacement therapy in the treatment of pancreatic steatorrhoea I. N. ARKS1, S. BANK2, AND EVELYN. AIRTH From the Gastrointestinal and Diagnostic Radioisotope Services, Groote
More informationHome Total Parenteral Nutrition for Adults
Home Total Parenteral Nutrition for Adults Policy Number: Original Effective Date: MM.08.007 05/21/1999 Line(s) of Business: Current Effective Date: PPO, HMO, QUEST Integration 05/27/2016 Section: Home
More informationSmall-Bowel and colon Transit. Mahsa Sh.Nezami October 2016
Small-Bowel and colon Transit Mahsa Sh.Nezami October 2016 Dyspeptic symptoms related to dysmotility originating from the small bowel or colon usually include : Abdominal pain Diarrhea Constipation However,
More informationIndividual Study Table Referring to Part of the Dossier. Volume:
SYNOPSIS Name of Sponsor/Company Protocol no.: CR002665 Title of Study: A Phase II, Randomized, Investigator-Blinded, Parallel-Group Pilot Study Evaluating the Safety, Palatability and Efficacy of Four
More informationFecal fat, bile acid, and sterol excretion and biliary lipid changes in jejunoileostomy patients1 2
Fecal fat, acid, and sterol excretion and biliary lipid changes in jejunoileostomy patients1 2 William W. Faloon, M.D.,3 Albert Rubulis, Ph.D.,4 John Knipp, M.D.,5 Char/es D. Sherman, M.D.,6 and Mary S.
More informationEffect of chenodeoxycholic acid treatment in gallstone subjects
12 LI T. C. Northfield, N. F. LaRusso, A. F. Hofmann, and J. L. Thistle Effect of chenodeoxycholic acid treatment in gallstone subjects T. C. NORTHFIELD, N. F. LaRUSSO, A. F. HOFMANN, AND J. L. THISTLE
More informationRADIATION INDUCED SMALL BOWEL DISEASE. Dr Mnguni Supervisor: Dr Lohlun Radiation Oncology
RADIATION INDUCED SMALL BOWEL DISEASE Dr Mnguni Supervisor: Dr Lohlun Radiation Oncology INTRODUCTION Radiation therapy is not regularly indicated in the treatment of small bowel disease. Reasons are complex
More informationSaliva & Feces analysis
Saliva & Feces analysis Saliva analysis What is Saliva? Watery substance present in humans and animals and secreted by salivary glands and aids in digestion It is a filtrate of plasma Contains electrolytes,
More informationDiet and Gastrointestinal Problems
Chapter 20 Diet and Gastrointestinal Problems Objectives Explain uses of diet therapy in gastrointestinal disturbances Identify foods allowed and disallowed in therapeutic diets discussed Adapt normal
More informationThe effect of cholestyramine on intestinal absorption
Gut, 1975, 16, 93-98 The effect of cholestyramine on intestinal absorption R. J. WEST AND J. K. LLOYD From the Department of Child Health, Institute of Child Health, Guildford Street, London SUMMARY Cholestyramine
More informationProduct Monograph. GE Healthcare. 370 KBq Capsules Radiodiagnostic Agent (Measurement of Bile Acid Pool Loss)
GE Healthcare Product Monograph 370 KBq Capsules Radiodiagnostic Agent (Measurement of Bile Acid Pool Loss) GE Healthcare Canada Inc. 2300 Meadowvale Blvd., Mississauga, Ontario L5N 5P9 Control #: 105477
More informationNOTES: The Digestive System (Ch 14, part 2)
NOTES: The Digestive System (Ch 14, part 2) PANCREAS Structure of the pancreas: The pancreas produces PANCREATIC JUICE that is then secreted into a pancreatic duct. The PANCREATIC DUCT leads to the The
More informationGALLIUM CITRATE Ga 67 INJECTION
511945-0903 September 2003 USA Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, MA 01862 USA GALLIUM CITRATE Ga 67 INJECTION FOR DIAGNOSTIC USE DESCRIPTION: Gallium Citrate Ga 67
More informationIncreased colonic bile acid exposure: a relevant factor for symptoms and treatment in irritable bowel syndrome (IBS)
Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in irritable bowel syndrome (IBS) Bajor A et al. Gut 2015; 64: 84-92. Prescribing information can be found at the end
More informationANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD
ANTIHYPERLIPIDEMIA Darmawan,dr.,M.Kes,Sp.PD Plasma lipids consist mostly of lipoproteins Spherical complexes of lipids and specific proteins (apolipoproteins). The clinically important lipoproteins, listed
More informationNIH Public Access Author Manuscript Res Commun Chem Pathol Pharmacol. Author manuscript; available in PMC 2010 October 18.
NIH Public Access Author Manuscript Published in final edited form as: Res Commun Chem Pathol Pharmacol. 1986 July ; 53(1): 137 140. EFFECT OF BILE ON CYCLOSPORINE ABSORPTION IN DOGS Raman Venkataramanan
More informationpoints to the necessity in future to explore where cholesterol is stored, to what extent stored cholesterol can be
The Effects of Unsaturated Dietary Fats on Absorption, Excretion, Synthesis, and Distribution of Cholesterol in Man ScoTr M. GRUNDY and E. H. AHBENS, JR. From The Rockefeller University, New York 121 A
More informationCholestyramine Treatment Reduces Postprandial but not Fasting Serum Bile Acid Levels in Humans
GASTROENTEROLOGY 1982;83:1097-101 Cholestyramine Treatment Reduces Postprandial but not Fasting Serum Bile Acid Levels in Humans BO ANGELIN, INGEMAR BJORKHEM, KURT EINARSSON, and STAFFAN EWERTH The Departments
More informationVulnerability of keto bile acids to alkaline hydrolysis
Vulnerability of keto bile acids to alkaline hydrolysis G. Lepage, A. Fontaine, and C. C. Roy Department of Pediatrics, H6patal Ste-Justine and the University of Montreal, Montreal, Canada Summary Rigorous
More informationSequioa Education Systems, Inc. 1
Functional Diagnostic Medicine Training Program Module 2 The Functional Diagnostic Medicine Approach in the Treatment of Gastrointestinal Dysfunction and Disease Dr. Wayne L. Sodano, D.C., D.A.B.C.I. &
More informationNutrition Management in GI Diseases
Nutrition Management in GI Diseases Aryono Hendarto MD Nutrition & Metabolic Diseases Division Department of Child Health Cipto Mangunkusumo Hospital University of Indonesia 1 Patient s Care 1. Drugs 2.
More informationThe effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man
The effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man Scott M. Grundy, E. H. Ahrens Jr. J Clin Invest. 197;49(6):1135-1152. https://doi.org/1.1172/jci16329.
More informationBiomarkers of GI tract diseases. By Dr. Gouse Mohiddin Shaik
By Dr. Gouse Mohiddin Shaik Introduction The gastrointestinal (GI) tract is a complex system performing multiple biological functions which are anatomically distributed Site for food processing and absorption
More informationUnderstanding Exocrine Pancreatic Insufficiency (EPI) Important Information About What EPI Is and How It s Managed
Understanding Exocrine Pancreatic Insufficiency (EPI) Important Information About What EPI Is and How It s Managed What Is Exocrine Pancreatic Insufficiency (EPI)? Who Gets EPI? EPI is related to a few
More informationThe economy of the enterohepatic circulation of bile acids in the baboon. 1. Studies of controlled enterohepatic circulation of bile acids'
The economy of the enterohepatic circulation of bile acids in the baboon. 1. Studies of controlled enterohepatic circulation of bile acids' Richard N. Rediner: James W. Hawkins, and D. Michael Grace Department
More informationDiseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix
Diseases of the gastrointestinal system H Awad Lecture 2: small intestine/ part 2 and appendix Malabsorption most important causes of malabsorption: Celiac disease tropical sprue Lactase deficiency Whipple
More informationDiagnosing and Managing IBS in IBD Patients. September 2012
Diagnosing and Managing IBS in IBD Patients September 2012 Professor David S Sanders Consultant Gastroenterologist Royal Hallamshire Hospital & University of Sheffield Patient Comes to see you with GI
More informationComprehensive Digestive Stool Analysis 2.0
Comprehensive Digestive tool Analysis 2.0 Patient: BIAN DAVIE ex: M MN: 1232068556 eceived: January 30, 2013 Northshore Naturopathic Clinic Brian Davies ND 156 West 3rd t North Vancouver, BC V7M 1E8 Canada
More informationSC14 (JUN08SC1401) General CertiÞ cate of Education June 2008 Advanced Level Examination. APPLIED SCIENCE Unit 14 The Healthy Body
Surname Other Names For Examiner s Use Centre Number Candidate Number Candidate Signature General CertiÞ cate of Education June 2008 Advanced Level Examination APPLIED SCIENCE Unit 14 The Healthy Body
More informationMetabolism of Steroid and Amino Acid Moieties of Conjugated Bile Acids in Man
Metabolism of Steroid and Amino Acid Moieties of Conjugated Bile Acids in Man II. GLYCINE-CONJUGATED DIHYDROXY BILE ACIDS GERSHON W. HEPME, ALAN F. HOFMANN, and PAUL J. THOMAS From the Mayo Clinic and
More informationAdvances in CF therapies and their effect on GI manifestations. Presenter Disclosure Daniel Gelfond, MD Relationship related to this presentation
Advances in CF therapies and their effect on GI manifestations Daniel Gelfond, MD University of Rochester WNY Pediatric Gastroenterology Presenter Disclosure Daniel Gelfond, MD Relationship related to
More informationVictor Tambunan Department of Nutrition Faculty of Medicine Universitas Indonesia
Victor Tambunan Department of Nutrition Faculty of Medicine Universitas Indonesia 1 References Krause s Food & Nutrition Therapy 12th ed., 2008 ---- L.K. Mahan & S. Escott-Stump Modern Nutrition in Health
More informationSection Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, ,
IDP Biological Systems Gastrointestinal System Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, 504-568-2669, jbresl@lsuhsc.edu Overall Learning Objectives 1. Characterize
More informationValidation of a dietary record system for the estimation of daily cholesterol intake in individual outpatients13
Validation of a dietary record system for the estimation of daily cholesterol intake in individual outpatients13 Edith C. White, M.A., Donald J. McNamar Ph.D., and E. H. Ahrens, Jr., M.D. Introduction
More informationMonosaccharides: Little amounts Don t need any digestion
Slide 8 Digestion result in mono and disaccharides & alpha-dextrins (oligosaccharides) Alpha1-4 in sequences / alpha1-6 at branches Dietary carbohydrates: Polysaccharides: 1) Containing α(1,4)/ α(1,6)
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationGlencoe Health. Lesson 3 The Digestive System
Glencoe Health Lesson 3 The Digestive System Health espotlight Video BIG IDEA The digestive system provides nutrients and energy for your body through the digestion of food. New Vocabulary mastication
More informationWho Needs Parenteral Nutrition? Is Parenteral Nutrition An Appropriate Intervention?
Who Needs Parenteral Nutrition? 1 Is Parenteral Nutrition An Appropriate Intervention? Key questions to ask with initial consultation Can the gastrointestinal (GI) tract be utilized? Can the GI tract be
More informationEtiology, Assessment and Treatment
Etiology, Assessment and Treatment Andrew Tinsley MD, MS Associate Director of IBD Center Assistant Professor of Medicine Penn State College of Medicine Abbvie Janssen Nestle 1 To review the prevalence
More informationDigestive System. How your body obtains nutrients. Wednesday, March 2, 16
Digestive System How your body obtains nutrients Vocabulary Ingestion: food enters the system Physical and enzymatic breakdown begins Digestion: Further breakdown Chemical/enzymatic Vocabulary Absorption:
More informationUrinalysis and Body Fluids CRg. Feces. Feces. Unit 5. 5 Feces & miscellaneous handouts draft
Urinalysis and Body Fluids CRg Unit 5 5 & miscellaneous handouts draft Composition Bacteria, Cellulose & other undigested foodstuffs GI secretions, enzymes, bile pigments Cells Electrolytes and water Indications
More informationPERSISTENT DIARRHOEA. IAP UG Teaching slides
PERSISTENT DIARRHOEA 1 DEFINITION Prolongation of acute diarrhoea / dysentery for more than 14 days Generally associated with weight loss. 2 PROTRACTED DIARRHOEA Prolongation of acute diarrhoea or dysentery
More information